COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Pulmonary Involvement in Systemic Autoimmune Diseases - 1st Edition - ISBN: 9780444516527, 9780080515441

Pulmonary Involvement in Systemic Autoimmune Diseases, Volume 2

1st Edition

Series Editor: Ronald Asherson
Series Volume Editors: Andrea Doria Paolo Pauletto
eBook ISBN: 9780080515441
Paperback ISBN: 9780444559609
Hardcover ISBN: 9780444516527
Imprint: Elsevier Science
Published Date: 1st September 2004
Page Count: 314
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

Part I. Pathology.
1. Lung pathology in connective tissue diseases (D. Tansey, A.G. Nicholson).

Part II. Radiologic investigations in connective tissue diseases.
2. High resolution computed tomography of the lungs (T. Franquet).

Part III. Pulmonary hypertension.
3. Pulmonary arterial hypertension in connective tissue disease (C. Denton, C. Black).

Part IV. Vasculitides.
4. Wegener's granulomatosus: a pulmonary perspective (P. Lamprecht, A. Schnabel, W.L. Gross).
5. Vasculitic syndromes other than Wegener's granulomatosus (A. Bennett, D. D'Cruz).

Part V. Pulmonary involvement in connective tissue disorders.
6. Lung disease in lupus (A. Kao, J. Sabatine, S. Manzi).
7. Pulmonary involvement in the anti-phospholipid syndrome (G. Espinosa et al.).
8. Rheumatoid arthritis and the lung (J. David, S. Edmonds).
9. Sjogren's syndrome and the lung (P. Papiris, H. Moutsopoulos).
10. Interstitial disease in systemic sclerosis (N. Goh, R. du Bois).
11. Pulmonary complications of polymyositis and dermatomyositis (J. Deng, M. Keane, J. Lynch III).
12. Pulmonary involvement in miscellaneous connective tissue diseases (A. Wells, G. Davies).

Part VI. Drug-induced respiratory disease.
13. Drug induced respiratory disease in connective tissue disease (P. Camus).


In this book is found the information essential to diagnosing, managing and treating the lung complications of connective tissue diseases. This is a notoriously difficult area, which continues to puzzle clinicians, despite the fact that these disorders are increasingly frequent (as a result of longer survival in connective tissue disease).

In separate chapters, the major connective tissue diseases are reviewed, with detailed discussion of a variety of lung abnormalities, including pleural disease, parenchymal lung disease and pulmonary vascular disease. There are also invaluable overviews of lung histological and CT appearances in these disorders, and a deeply insightful chapter on drug-induced lung disease in connective tissue disease. The emphasis in this book is on accuracy of evaluation and the construction of a logical management plan, based on disease severity and intrinsic progressiveness.


No. of pages:
© Elsevier Science 2004
1st September 2004
Elsevier Science
eBook ISBN:
Paperback ISBN:
Hardcover ISBN:

Ratings and Reviews

About the Series Editor

Ronald Asherson

Affiliations and Expertise

Killarney, Johannesburg, South Africa

About the Series Volume Editors

Andrea Doria

Paolo Pauletto

Paolo Pauletto

Affiliations and Expertise

Professor of Internal Medicine, University of Padova Medical School, Italy